KUSUMAKAR SOODA
Allopathic & Osteopathic Physicians|Family Medicine CORPUS CHRISTI, TX NPI 1386830354
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TX CeQur Corporation All categories
General Payments — all program years on this page
$399.08
- Category: General Payments
- Program years: PY2022–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $144.70 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $144.70 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| CeQur Corporation | $36.33 | 1 |
| Lilly USA, LLC | $31.68 | 2 |
| Acerta Pharma LLC | $16.38 | 1 |
| Exact Sciences Corporation | $16.15 | 1 |
| Currax Pharmaceuticals LLC | $15.58 | 1 |
| PFIZER INC. | $14.70 | 1 |
| Amgen Inc. | $13.88 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089512514 | Currax Pharmaceuticals LLC | $15.58 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105331116 | AstraZeneca Pharmaceuticals LP | $16.38 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114910904 | Exact Sciences Corporation | $16.15 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117388272 | Amgen Inc. | $13.88 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126845286 | CeQur Corporation | $36.33 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132019070 | PFIZER INC. | $14.70 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135081100 | Lilly USA, LLC | $18.46 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135120515 | Lilly USA, LLC | $13.22 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.